INS and steatosis: Activator of protective IRE1/XBP1s signaling in live; improvement of systemic glucose metabolism and liver insulin action through IRE1-dependent remodeling of the hepatic transcriptome that reduces glucose production and steatosis. IXA4-stimulated IRE1 activation also enhances pancreatic function